Literature DB >> 20053487

[Infectious adverse events related to misuse of high-dose buprenorphine: a retrospective study of 42 cases].

D Grau1, N Vidal, V Faucherre, Y Léglise, V Pinzani, J-P Blayac, J Reynes, H Peyrière.   

Abstract

PURPOSE: Misuse of high-dose buprenorphine (HDB), mainly by injection, is responsible of frequent infectious adverse events.
METHODS: This is a retrospective study of infectious complications occurring in patients using HDB by injection. Forty-two cases were identified (29 men and ten women) and the data were collected between March 1999 and December 2008.
RESULTS: The infectious complications included cutaneous infections (27 cases), endocarditis (nine cases), osteoarticular infections (four spondylodiscitis and one sacroiliitis), and a vascular embolism with decrease in visual acuity.
CONCLUSION: The results of HDB maintenance treatment must be improved, both from the point of view of substitution and to limit its misuse by intravenous route injection. Health professionals have to play an important role in drug addict patients' education and supervision, to prevent buprenorphine injection and related infectious complications. 2009 Société nationale française de médecine interne (SNFMI). Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20053487     DOI: 10.1016/j.revmed.2009.10.433

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  3 in total

1.  Crushed and injected buprenorphine tablets: characteristics of princeps and generic solutions.

Authors:  Régis Bouquié; Laura Wainstein; Paul Pilet; Jean-Marie Mussini; Guillaume Deslandes; Johann Clouet; Eric Dailly; Pascale Jolliet; Caroline Victorri-Vigneau
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

2.  Epidemiological and clinical features, ultrasound findings and prognosis of right-sided infective endocarditis in a teaching hospital in Ouagadougou.

Authors:  Nobila Valentin Yameogo; Kongnimisson Apoline Sondo; Aime Arsene Yameogo; Larissa Justine Kagambega; D Germain Mandi; K Jonas Kologo; Georges R C Millogo; B Jean Yves Toguyeni; Andre K Samadoulougou; N Jean-Paul Kabore; Patrice Zabsonre
Journal:  Cardiovasc J Afr       Date:  2013-06       Impact factor: 1.167

3.  Community acquired fungemia caused by Candida pulcherrima: diagnostic contribution of MALDI-TOF mass spectrometry.

Authors:  Laurène Deconinck; Agnès Meybeck; Maxime Pradier; Pierre Patoz; Hugues Melliez; Eric Senneville
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-03-08       Impact factor: 3.944

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.